ENTREP1 and cancer: Based on these results, we hypothesize that low expression of ENTREP potentiates the increase in cancer stem cells (which probably shortens the relapse‐free survival of patients) but not the secondary transformation or chemoresistance of them (which probably shortens the overall survival of patients).